Literature DB >> 32944640

SOX6: a double-edged sword for Ewing sarcoma.

Aruna Marchetto1, Thomas G P Grünewald1,2,3,4.   

Abstract

Developmental pathways play an important role in cancer. We have recently demonstrated that the constitutive activation of the developmental transcription factor SOX6 via the fusion oncoproteinne EWSR1-FLI1 (Ewing sarcoma breakpoint region 1 - Friend leukemia virus integration 1) contributes to the aggressive phenotype of Ewing sarcoma but on another hand provides an opportunity for targeted therapy.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  EWSR1-FLI1; Elesclomol; Ewing sarcoma; SOX6; biomarker; oxidative-stress; vulnerability

Year:  2020        PMID: 32944640      PMCID: PMC7469519          DOI: 10.1080/23723556.2020.1783081

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  9 in total

Review 1.  Ewing sarcoma.

Authors:  Thomas G P Grünewald; Florencia Cidre-Aranaz; Didier Surdez; Eleni M Tomazou; Enrique de Álava; Heinrich Kovar; Poul H Sorensen; Olivier Delattre; Uta Dirksen
Journal:  Nat Rev Dis Primers       Date:  2018-07-05       Impact factor: 52.329

Review 2.  Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer.

Authors:  Jianbiao Zhou; Wee-Joo Chng
Journal:  Mitochondrion       Date:  2012-06-27       Impact factor: 4.160

3.  Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells.

Authors:  Ying Qu; Jinhua Wang; Myung-Shin Sim; Bingya Liu; Armando Giuliano; James Barsoum; Xiaojiang Cui
Journal:  Breast Cancer Res Treat       Date:  2009-07-16       Impact factor: 4.872

4.  Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.

Authors:  Thomas G P Grünewald; Virginie Bernard; Pascale Gilardi-Hebenstreit; Virginie Raynal; Didier Surdez; Marie-Ming Aynaud; Olivier Mirabeau; Florencia Cidre-Aranaz; Franck Tirode; Sakina Zaidi; Gaëlle Perot; Anneliene H Jonker; Carlo Lucchesi; Marie-Cécile Le Deley; Odile Oberlin; Perrine Marec-Bérard; Amélie S Véron; Stephanie Reynaud; Eve Lapouble; Valentina Boeva; Thomas Rio Frio; Javier Alonso; Smita Bhatia; Gaëlle Pierron; Geraldine Cancel-Tassin; Olivier Cussenot; David G Cox; Lindsay M Morton; Mitchell J Machiela; Stephen J Chanock; Patrick Charnay; Olivier Delattre
Journal:  Nat Genet       Date:  2015-07-27       Impact factor: 38.330

5.  Elesclomol induces cancer cell apoptosis through oxidative stress.

Authors:  Jessica R Kirshner; Suqin He; Vishwasenani Balasubramanyam; Jane Kepros; Chin-Yu Yang; Mei Zhang; Zhenjian Du; James Barsoum; John Bertin
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

6.  Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes.

Authors:  Julian Musa; Florencia Cidre-Aranaz; Marie-Ming Aynaud; Martin F Orth; Maximilian M L Knott; Olivier Mirabeau; Gal Mazor; Mor Varon; Tilman L B Hölting; Sandrine Grossetête; Moritz Gartlgruber; Didier Surdez; Julia S Gerke; Shunya Ohmura; Aruna Marchetto; Marlene Dallmayer; Michaela C Baldauf; Stefanie Stein; Giuseppina Sannino; Jing Li; Laura Romero-Pérez; Frank Westermann; Wolfgang Hartmann; Uta Dirksen; Melissa Gymrek; Nathaniel D Anderson; Adam Shlien; Barak Rotblat; Thomas Kirchner; Olivier Delattre; Thomas G P Grünewald
Journal:  Nat Commun       Date:  2019-09-11       Impact factor: 14.919

7.  Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate.

Authors:  Patrick Smits; Peter Dy; Srijeet Mitra; Véronique Lefebvre
Journal:  J Cell Biol       Date:  2004-03-01       Impact factor: 10.539

8.  Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.

Authors:  Michael J Monument; Kirsten M Johnson; Elizabeth McIlvaine; Lisa Abegglen; W Scott Watkins; Lynn B Jorde; Richard B Womer; Natalie Beeler; Laura Monovich; Elizabeth R Lawlor; Julia A Bridge; Joshua D Schiffman; Mark D Krailo; R Lor Randall; Stephen L Lessnick
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

9.  Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma.

Authors:  Aruna Marchetto; Shunya Ohmura; Martin F Orth; Maximilian M L Knott; Maria V Colombo; Chiara Arrigoni; Victor Bardinet; David Saucier; Fabienne S Wehweck; Jing Li; Stefanie Stein; Julia S Gerke; Michaela C Baldauf; Julian Musa; Marlene Dallmayer; Laura Romero-Pérez; Tilman L B Hölting; James F Amatruda; Andrea Cossarizza; Anton G Henssen; Thomas Kirchner; Matteo Moretti; Florencia Cidre-Aranaz; Giuseppina Sannino; Thomas G P Grünewald
Journal:  Nat Commun       Date:  2020-05-15       Impact factor: 14.919

  9 in total
  3 in total

1.  Clinical implications and genetical insights of SOX6 expression in acute myeloid leukemia.

Authors:  Yan Li; Duanfeng Jiang; Qin Zhang; Enyi Liu; Haigang Shao
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-19       Impact factor: 4.322

Review 2.  Preeclampsia: Cardiotonic Steroids, Fibrosis, Fli1 and Hint to Carcinogenesis.

Authors:  Natalia I Agalakova; Nikolai I Kolodkin; C David Adair; Alexander P Trashkov; Alexei Y Bagrov
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

3.  Identification of a novel circ_0001946/miR-1290/SOX6 ceRNA network in esophageal squamous cell cancer.

Authors:  Jianjun Wang; Wenjian Yao; Jiwei Li; Quan Zhang; Li Wei
Journal:  Thorac Cancer       Date:  2022-04-12       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.